Compugen to Present at the 12th Annual Needham Healthcare Conference

Compugen Ltd. (NASDAQ: CGEN) today announced that its President and Chief Executive Officer, Dr. Anat Cohen-Dayag, will be presenting at the 12th Annual Needham Healthcare Conference in New York on Tuesday, April 30 at 10:00 AM ET.

The presentation will be available after the conference on Compugen's website, at http://www.cgen.com.

About CompugenCompugen is a leading drug discovery company focused on therapeutic proteins and monoclonal antibodies to address important unmet needs in the fields of immunology and oncology. The Company utilizes a broad and continuously growing integrated infrastructure of proprietary scientific understandings and predictive platforms, algorithms, machine learning systems and other computational biology capabilities for the in silico (by computer) prediction and selection of product candidates, which are then advanced in its Pipeline Program. The Company's business model includes collaborations covering the further development and commercialization of selected product candidates from its Pipeline Program and various forms of research and discovery agreements, in both cases providing Compugen with potential milestone payments and royalties on product sales or other forms of revenue sharing. In 2012, Compugen established operations in California for the development of oncology and immunology monoclonal antibody therapeutic candidates against Compugen drug targets. For additional information, please visit Compugen's corporate website at www.cgen.com.